Research on obesity, its causes, and its treatment. Covers GLP-1 weight-loss drugs, diet, metabolic health, treatment guidelines, and obesity in children.
Researchers transplanted gut microbes from a naturally obesity-resistant shrew to high-fat-diet-induced obese mice, improving microbiome diversity. This approach resulted in decreased weight gain in the obese mice, suggesting potential therapeutic benefits for human obesity.
A new study from the University of Wisconsin-Madison suggests that reducing isoleucine intake can extend lifespan and improve health outcomes. Mice on a low-isoleucine diet lived 33% longer and showed better health markers than those on a balanced diet.
A simulation study suggests that a soft drink tax in Germany would reduce sugar consumption and illness rates, including type 2 diabetes, resulting in significant financial savings. The estimated economic benefits of introducing such a tax range from 9.5 billion to 16 billion euros over the next two decades.
A study by the Keck School of Medicine of USC found that liver cancer risk increases with each successive generation of Mexican Americans, particularly among men. The research analyzed data from over 30,000 participants and found third-generation Mexicans to be 66% more likely to develop liver cancer than first-generation individuals.
A study of over 20,000 middle-aged US adults found lower income status linked to increased hypertension risk. Higher-income adults faced rising rates of diabetes and obesity. Targeted public health initiatives are needed to address growing cardiovascular mortality among middle-aged adults.
Researchers from Karolinska Institutet found a weaker association between adolescent physical fitness and later cardiovascular disease risk. High BMI remained a strong individual risk factor for cardiovascular disease in late adolescence.
Researchers discovered that individuals with obesity expel more energy at night compared to those with a healthy weight. During the day, people with obesity have higher insulin levels, indicating their body is working harder to process glucose.
A new study funded by Cancer Research UK reveals that smoking tobacco causes 20.8 million years of life loss each year, with four preventable risk factors contributing to over 30 million years of life lost annually. The study suggests that action on a global scale could save millions of lives from preventable cancers.
Researchers aim to optimize digital weight-loss programs for rural populations by adding human components, such as weekly group video sessions and individual coaching calls. The goal is to help residents manage their weight and fight the obesity epidemic in areas with limited access to in-person programs.
A 20% reduction in major adverse cardiovascular events has been observed for patients with obesity but no history of diabetes taking semaglutide. This study marks a significant milestone, demonstrating the cardiovascular benefits of semaglutide beyond its weight loss effects.
Researchers found that people with overweight or obesity who took semaglutide for over 3 years had a 20% lower risk of heart attack, stroke, or death from cardiovascular disease. The study showed significant weight loss and improved cardiovascular outcomes in adults without diabetes.
A recent clinical trial found that semaglutide significantly reduced cardiovascular events in adults with overweight or obesity who do not have diabetes. The medication was shown to lower the risk of death from cardiovascular causes, nonfatal heart attacks, and strokes by 20% compared to placebo.
Researchers from Helmholtz Munich discovered that GIP decreases body weight by interacting with specific inhibitory neurons in the brain, offering a revolutionary approach to patients worldwide. The study reveals the underlying molecular mechanisms of GIPR:GLP-1R co-agonists and their potential as next-generation anti-obesity drugs.
The OBCT Project aims to identify the causes of obesity and design guidelines to tackle the problem. The study will analyze data from millions of individuals across Europe and map 'obesogenic environments' that promote weight gain or prevent weight loss.
Researchers found that a high-sugar diet causes insulin resistance in the brain, reducing its ability to remove neuronal debris and increasing the risk of neurodegenerative diseases. This study provides insight into how obesity-inducing diets contribute to disease risk.
The American Gastroenterological Association suggests a balanced approach when treating patients on GLP-1 RAs undergoing endoscopic procedures. AGA recommends proceeding with the procedure as planned for patients who followed standard pre-procedure fasting instructions and do not have symptoms suggesting retained gastric contents.
Researchers at Johns Hopkins Medicine found that people with high body mass indexes (BMIs) do not pose a significant risk for postoperative complications following chest masculinization surgery. Despite this, BMI was still used to determine eligibility for the procedure in many cases.
A recent study has found that transgender adults living in rural areas of the US are more likely to have cardiovascular disease risk factors such as tobacco use, obesity, and high blood pressure. The research highlights the need for targeted interventions to reduce health disparities among this population.
A study found that physicians who presented treatments for obesity as good news and an opportunity were more successful in helping patients lose weight. Patients who received counseling with a positive and optimistic tone had significantly higher weight loss outcomes compared to those who received neutral or negative advice.
A recent meta-analysis found that women in low- and middle-income countries are disproportionately affected by obesity, with risks ranging from 2-3 times higher than men. This disparity is most pronounced in the Sub-Saharan region, where women are up to 10 times more likely to have obesity.
A recent study published in Nutrients found that daily strawberry consumption can improve cognitive performance and reduce depressive symptoms in middle-aged adults. The research, led by Professor Robert Krikorian, suggests that strawberries contain antioxidants and micronutrients that may help mitigate the risk of dementia.
A new study from Tulane University found that frequent salt consumption is associated with a higher risk of developing Type 2 diabetes. The study surveyed over 400,000 adults and found participants who regularly added salt had a 13% to 39% increased risk of developing the disease compared to those who never or rarely used salt.
Researchers found that as cats gained weight, their gastrointestinal transit time decreased, reducing nutrient extraction. The study also revealed changes in gut microbial composition, with an increase in Bifidobacterium and a decrease in Collinsella, opposite to what has been seen in overweight humans.
Researchers found an epigenetic signature in cheek cells of obese twins that differs from their thinner siblings, suggesting a susceptibility to obesity may be written into molecular processes. The discovery could lead to a simple cheek swab test for an obesity biomarker and enable earlier prevention methods.
Researchers at University of British Columbia find a direct link between high insulin levels and pancreatic cancer, highlighting the importance of keeping insulin levels within a healthy range. The study suggests that excessive insulin overstimulates pancreatic acinar cells, leading to inflammation and precancerous cell development.
A collaborative project led by UTHSC researcher Dr. Liza Makowski is exploring the complex interplay between obesity, the immune system, and cancer. The team aims to identify biomarkers that may provide therapeutic guidance for obese patients with specific types of cancers.
A recent scientific publication found that sterilized dogs of different sizes exhibit varying levels of obesity, with small breeds at highest risk and giant breeds at lowest. The study also discovered that the optimal time for spaying/neutering differs by breed size, with young large breeds facing a higher risk of obesity.
A new UK study finds that people with eating disorders are 2.11 times more likely to report physical multimorbidity. Anxiety, insomnia, and perceived stress are key influencers in this relationship.
A phase 3 clinical trial demonstrated tirzepatide's effectiveness in achieving an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or overweight comorbidities. Participants who received tirzepatide achieved a total mean weight loss of 26.6%, compared to 3.8% for those on placebo.
A recent clinical study at the University of Leipzig Medical Center found that ultrasound scans of the liver and kidneys were significantly lower in quality in obese patients. Modern probes with matrix technology improve image quality by achieving greater penetration depth into tissue.
Buck Institute researchers discover that advanced glycation end products (AGEs) in processed foods increase hunger and test willpower, contributing to overeating and obesity. By understanding the biochemical signaling pathway behind AGEs, scientists may develop strategies to limit their accumulation and promote healthy eating.
Research at Chiba University discovered that N-acetylglucosamine 6-O-sulfation of mucin glycans prevents obesity and inflammation in a murine model. The findings suggest that enhancing sulfation may improve the barrier function of epithelial tissues, providing relief against intestinal inflammation.
A new study analyzing English primary care records found that hypertension, obesity, diabetes, and low HDL cholesterol confer a higher risk of dementia in South Asian and Black people compared to White individuals. The results suggest tailored dementia prevention efforts should be targeted towards minority ethnic groups.
A new study found that pre-pregnancy obesity is a primary driver of future cardiovascular disease risk, rather than pregnancy complications. The research followed 4,216 individuals from early pregnancy to postpartum and found those with overweight or obese BMI had a higher risk of developing hypertensive disorders during pregnancy.
Research found that poor sleep quality is associated with less muscle strength and mass, more body fat, anxiety, and depression in obese older people. The study emphasizes the importance of addressing sleep quality to prevent negative health outcomes in this population.
Research suggests that high-dose dietary prebiotics can reduce reward-related brain activation in response to high-calorie food stimuli. The study found a shift in the composition of the gut bacteria, which may underlie the altered brain response towards high-calorie food cues.
Researchers discovered five types of macrophages in fat tissue, with one subtype promoting inflammation and another quelling it. The findings challenge the long-held assumption that pro-inflammatory macrophages are solely responsible for obesity-related inflammation.
Research reveals that low muscle mass is associated with a two-fold risk of death from cardiovascular disease in individuals with diabetes. The study found that body composition, not just weight loss, plays a crucial role in managing weight in people with diabetes.
A UCLA-led team has discovered the nerve supply that activates brown adipose tissue, a potential key to treating obesity. The study found nerve branches in all eight cadavers dissected, which may lead to using nerves to stimulate BAT activity for weight loss.
A study published in Diabetes Care found that obesity, hypertension, and dyslipidemia alter cardiac energy production by interfering with metabolic substrate uptake. The research reveals early changes in apparently healthy middle-aged individuals, highlighting the importance of identifying mechanisms involved in heart disease onset.
Studies show that people with metabolically healthy obesity (MHO) have a 50% increased risk of coronary heart disease, despite not exhibiting metabolic complications. This raises questions about the validity of the MHO concept.
A new study published in Nature Communications found that global sugary drink consumption increased by at least 16% since 1990, with the highest intakes observed in Latin America and Sub-Saharan Africa. The study also reveals significant regional differences and correlations between sugary drink intake and socio-economic status.
A new study published in Exp. Mol. Med. has identified Thrap3 as a key player in exacerbating non-alcoholic fatty liver disease (NAFLD) by inhibiting AMPK, a crucial regulator of fat metabolism. Inhibiting Thrap3 expression presents a promising avenue for treating NAFLD.
Researchers discovered that in obesity, low-density lipoprotein (LDL) does not function normally, increasing the risk of cardiovascular disease. However, after bariatric surgery, LDL quality improves and correlates with weight loss, suggesting a lower risk of CVD.
A worldwide audit of testosterone deficiency in men with type 2 diabetes found that testosterone replacement therapy improves glycaemic control for up to 2 years. The study suggests that the ongoing effect of testosterone on insulin resistance and fat reduction contributes to the improvement in blood sugar levels.
Researchers at the University of Birmingham found that individuals with fatty liver disease are three times more likely to have a personality disorder than those without. Lifestyle modifications, such as changes in diet and exercise, can prevent disease progression but often fail to be implemented due to mental health factors.
A new study found that only about 3% of adults in England with overweight or obesity were referred to publicly funded weight management programs. The study also showed large regional differences in access to these programs, with some areas having much higher rates of referral.
A new study suggests that obese women experience an increase in menopause symptom prevalence and lower efficacy of hormone therapy. Women with obesity are more likely to self-identify as Black, report hot flashes, genitourinary symptoms, mood disturbances, and decreased libido.
A new study published in the New England Journal of Medicine found that semaglutide significantly improves symptoms and physical limitations associated with heart failure. Patients who received the medication lost an average of 11% of their body weight and showed improved walking distances, compared to those on a placebo.
A study published in The Journal of Physiology found that exercise suppresses hunger by acting on hormones and metabolites. Researchers suggest that understanding these mechanisms could lead to new treatments for obesity.
A new exercise-mimicking drug, SLU-PP-332, has shown promising results in obese mice, leading to weight loss and increased muscle activity without increasing physical activity. The drug works by boosting a natural metabolic pathway, making the body act like it is training for a marathon, resulting in faster metabolism of fat.
A study found that 80.3% of patients with metastatic breast cancer who received standard care treatment with alpelisib developed hyperglycemia, with 40.2% experiencing serious hyperglycemia. Lifestyle interventions and medication may help improve blood sugar levels and reduce the risk of needing to discontinue the drug.
A new meta-analysis of 22 clinical trials found that tirzepatide is more effective than semaglutide in controlling blood sugar levels and promoting weight loss. The study showed that higher doses of tirzepatide resulted in greater reductions in HbA1c levels and body weight compared to semaglutide.
Researchers at Helmholtz Munich discovered how exercise influences muscle function, immune cells, and metabolism in conditions like obesity and type 2 diabetes. They found that regulatory T cells play a critical role in controlling muscle function and regeneration.
Researchers found a 55% reduction in lymphoma risk and a 40% overall reduction in blood cancer risk among bariatric surgery patients. Women with high blood sugar at the start of the study benefited most from the surgery.
A new model for producing human brown fat cells in vitro has been developed, providing a potential solution for treating obesity and type 2 diabetes. The researchers identified key cellular signaling cues that lead to brown adipocyte formation and successfully reproduced this process in human pluripotent stem cells.
A study by the University of Gothenburg reveals that obesity significantly worsens life expectancy and mortality risks in individuals with bipolar disorders. The findings show a rapid increase in BMI among those with bipolar disorders, leading to a higher risk of premature death and comorbidity.
Despite recent advances in obesity research, governments struggle to curb rising rates, with experts identifying key unanswered questions about the causes of obesity. The intricacies of body weight regulation, energy demand sensing, and environmental factors are still unclear, highlighting the need for continued research.
Researchers found that almond-supplemented diets resulted in significant weight loss and improved cardiometabolic outcomes. The study demonstrated the benefits of nuts as part of a balanced weight loss diet, with almonds providing unsaturated fats that can improve blood cholesterol levels and contribute to a healthy heart.
A randomized controlled trial found that high-protein and normal-protein diets were both effective in improving glucose control, weight loss, and body composition in adults with Type 2 diabetes. The study suggests that individuals can choose a dietary pattern that suits their preferences while still achieving significant health benefits.